Pharmaceutical-Biotech Construction Activity Remains Steady
During the first six months of this year, the pharmaceutical-biotech industry completed construction on a total of 31 new plants and research centers across North America, according to a recent report from Industrial Info Resources, based in Sugar Land, Texas. The new plants included both grassroot facilities as well as the renovation of existing buildings.
Although the 2008 figures represent a decline of 10% over the same period last year (when 34 new plants opened), the total investment value of $1.7 billion has remained the same. Sources for this new activity include private industry, commercial developers, universities, and the federal government.
From a regional standpoint, the Great Lakes and Southwest regions both hosted six new plant openings since the beginning of 2008. With six months remaining in the year, the sector as a whole is expecting another 52 plants and laboratories to open before year's end.
Want to use this article? Click here for options!
© 2012 Penton Business Media, Inc.
Latest Articles
Solar kit
May 18, 2012 8:21 AM
Cable reel/stand combo unit
May 17, 2012 8:21 AM
Garage/utility lamp
May 16, 2012 9:26 AM
Trending Articles
Acceptable Use Policy blog comments powered by Disqus
advertisement
what's wrong here?
What's Wrong Here?
May 10, 2012 12:44 PM
View all What's Wrong Here?
What's Wrong Here
Sponsored By:
product spotlight
Solar kit
May 18, 2012 8:21 AM
Designed to support the company’s Piccolo and Concerto C2000 MCUs, the Solar Explorer kit features a non-isolated design ...
View all 2012 Product Spotlights
Free Product Info
Our Product Information site is the ultimate online resource for products and services offered by Advertisers featured in our Magazine. This service is provided as a quick and easy way to request Product Information online. Get FREE product information now.



































